Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade B 7.1 1.14% 0.08
OVID closed down 1.68 percent on Tuesday, August 11, 2020, on 35 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical OVID trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 1.14%
Bollinger Band Squeeze Range Contraction 1.14%
20 DMA Support Bullish -0.56%
MACD Bullish Signal Line Cross Bullish -0.56%
Bollinger Band Squeeze Range Contraction -0.56%
Outside Day Range Expansion -0.56%
Crossed Above 20 DMA Bullish -1.25%
Bollinger Band Squeeze Range Contraction -1.25%
Fell Below 20 DMA Bearish 2.45%
MACD Bullish Centerline Cross Bullish 2.45%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Biopharmaceutical Organ Systems Disorders Neurological Disorders Epilepsy Genodermatoses Sedatives Syndromes Anticonvulsants Fragile X Syndrome

Is OVID a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 9.4
52 Week Low 1.74
Average Volume 1,459,344
200-Day Moving Average 4.33
50-Day Moving Average 6.75
20-Day Moving Average 6.93
10-Day Moving Average 6.84
Average True Range 0.50
ADX 20.93
+DI 20.07
-DI 13.50
Chandelier Exit (Long, 3 ATRs ) 6.70
Chandelier Exit (Short, 3 ATRs ) 7.54
Upper Bollinger Band 7.55
Lower Bollinger Band 6.31
Percent B (%b) 0.57
BandWidth 17.91
MACD Line 0.05
MACD Signal Line 0.04
MACD Histogram 0.01
Fundamentals Value
Market Cap 172.69 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -1.45
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.01
Resistance 3 (R3) 8.03 7.73 7.85
Resistance 2 (R2) 7.73 7.47 7.72 7.79
Resistance 1 (R1) 7.37 7.32 7.22 7.35 7.73
Pivot Point 7.07 7.07 6.99 7.06 7.07
Support 1 (S1) 6.71 6.81 6.56 6.69 6.31
Support 2 (S2) 6.41 6.66 6.40 6.25
Support 3 (S3) 6.05 6.41 6.20
Support 4 (S4) 6.03